Arbutus Biopharma Corp
ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31
Reports and events: 558 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2207:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-006753 |
| 2026-08-2107:53 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-099390 |
| 2026-08-1207:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001447028-26-000045 |
| 2026-08-1207:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005442 |
| 2026-07-1607:31 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-004708 |
| 2026-05-2716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001447028-26-000024 |
| 2026-05-1307:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001447028-26-000021 |
| 2026-05-1307:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003346 |
| 2026-04-2817:54 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-26-001101 |
| 2026-04-1507:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-002458 |
| 2026-04-1417:02 ET | DEF 14A | Proxy statementPeriod 2026-05-26 | 0001140361-26-014623 |
| 2026-04-1319:56 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-26-000973 |
| 2026-03-2307:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001838 |
| 2026-03-2307:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001447028-26-000017 |
| 2026-03-0316:16 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-001299 |
| 2026-02-2016:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-000979 |
| 2026-02-0616:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-000676 |
| 2026-01-1607:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-000303 |
| 2025-12-1108:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-007879 |
| 2025-11-1307:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-007256 |
| 2025-11-1307:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001447028-25-000126 |
| 2025-10-0708:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-006316 |
| 2025-09-1009:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-005815 |
| 2025-08-0607:32 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001447028-25-000115 |
| 2025-08-0607:31 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-005076 |
| 2025-06-2507:31 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-004094 |
| 2025-05-2316:08 ET | 8-K | 5.07 Shareholder vote results | 0001447028-25-000104 |
| 2025-05-1417:21 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001447028-25-000099 |
| 2025-05-1407:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-003153 |
| 2025-05-0706:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-002841 |
| 2025-04-2306:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-002401 |
| 2025-04-0416:05 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0001140361-25-012305 |
| 2025-04-0316:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001447028-25-000093 |
| 2025-03-2707:31 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001447028-25-000083 |
| 2025-03-2707:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001760 |
| 2025-03-0309:24 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-001188 |
| 2025-02-2507:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-001049 |
| 2025-02-2109:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-25-000560 |
| 2025-01-1307:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-000193 |
| 2024-11-1511:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-006400 |
| 2024-11-0616:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001447028-24-000087 |
| 2024-11-0607:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-006039 |
| 2024-10-1508:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-005618 |
| 2024-10-1116:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001447028-24-000084 |
| 2024-08-0816:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001447028-24-000072 |
| 2024-08-0516:13 ET | 8-K | 7.01 Regulation FD disclosure | 0001447028-24-000066 |
| 2024-08-0107:31 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-004324 |
| 2024-06-0611:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-003323 |
| 2024-06-0506:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-003302 |
| 2024-05-2816:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001447028-24-000061 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:27 ET. Listed shows no prices and gives no investment advice.